Fremantle, Australia

Alan David Payne

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Glycosynnovations Pty Ltd. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan David Payne. Retrieved from https://idiyas.com/inventor/alan-david-payne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alan David Payne

Introduction

Alan David Payne, an accomplished inventor based in Fremantle, Australia, has made significant strides in the field of glycanics. His innovative approach to therapeutic applications has the potential to impact various medical treatments, showcasing the importance of research and development in health sciences.

Latest Patents

Alan is the proud inventor of a patent titled "Therapeutic agents and methods of producing same." This invention relates to glycanics and focuses on the generation of glycoconjugates for therapeutic use. The process of preparing these glycoconjugates is an integral aspect of his patent, aimed at improving therapeutic outcomes in patient care.

Career Highlights

Alan works at Glycosynnovations Pty Ltd, where he utilizes his expertise in glycanics to further explore therapeutic possibilities. His innovative spirit and commitment to research make him an essential contributor to the advancements in medical technologies. Despite holding a solitary patent, his work signifies a dedication to quality and potential impact in the therapeutic domain.

Collaborations

Collaboration plays a vital role in Alan’s success. He works alongside talented professionals such as Bruno Basic and Shifaza Mohamed. Their combined knowledge and expertise help drive research initiatives at Glycosynnovations, fostering an environment of innovation.

Conclusion

In conclusion, Alan David Payne exemplifies the innovative spirit essential for advancements in therapeutic agents. His patent signifies a meaningful contribution to the field of glycanics, demonstrating how dedicated inventors can lead to groundbreaking discoveries in health care. Alan's collaborations further enhance the potential for future innovations, ensuring his work will resonate within the scientific community for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…